Expression of BAFF in the trophoblast and decidua of normal early pregnant women and patients with recurrent spontaneous miscarriage

Chinese Medical Journal

Volumn 121, Issue 4, 2008, Pages 309-315

  Guo, Wen Jing ^a,b   Qu, Xun ^a   Yang, Mei Xiang ^a   Zhang, Wei Dong ^b,c   Liang, Lu ^a   Shao, Qian Qian ^a   Kong, Bei Hua ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

^c SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY   (China)

Author keywords

B lymphocyte stimulator; Maternal fetal immunology; Recurrent spontaneous abortion

Indexed keywords

B CELL ACTIVATING FACTOR; B CELL ACTIVATING FACTOR RECEPTOR; INTERLEUKIN 10; MESSENGER RNA; TNFSF13B PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL SPECIFICITY; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTROPHOBLAST; DECIDUA; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOTHER FETUS RELATIONSHIP; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RECURRENT ABORTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPONTANEOUS ABORTION; SYNCYTIOTROPHOBLAST; TROPHOBLAST; WESTERN BLOTTING; CHEMISTRY; GENETICS; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; PREGNANCY; TH1 CELL; TH2 CELL;

ABORTION, HABITUAL; B-CELL ACTIVATING FACTOR; DECIDUA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-10; PREGNANCY; RNA, MESSENGER; TH1 CELLS; TH2 CELLS; TROPHOBLASTS;

EID: 41649121070     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200802020-00006     Document Type: Article

References (40)

1. Hunt JS, Petroff MG, McIntire RH, Ober C. HLA-G and immune tolerance in pregnancy. FASEB J 2005; 19: 681-693.
2. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 1995; 270: 1189-1192.
3. Guller S, LaChapelle L. The role of placental Fas ligand in maintaining immune privilege at maternal-fetal interfaces. Semin Reprod Endocrinol 1999; 17: 39-44.
4. Choi C, Benveniste EN. Fas ligand/Fas system in the brain: regulator of immune and apoptotic responses. Brain Res Brain Res Rev 2004; 44: 65-81.
5. Niederkorn JY. See no evil, hear no evil, do no evil: the lessons of immune privilege. Nat Immunol 2006; 7: 354-359.
6. Chen HL, Yang YP, Hu XL, Yelavarthi KK, Fishback JL, Hunt JS. Tumor necrosis factor alpha mRNA and protein are present in human placental and uterine cells at early and late stages of gestation. Am J Pathol 1991; 139: 327-335.
7. Runic R, Lockwood CJ, Ma Y, Dipasquale B, Guller S. Expression of Fas ligand by human cytotrophoblasts: implications in placentation and fetal survival. J Clin Endocrinol Metab 1996; 81: 3119-3122.
8. Hunt JS, Chen HL, Miller L. Tumor necrosis factors: pivotal components of pregnancy? Biol Reprod 1996; 54: 554-562.
9. Chung IB, Yelian FD, Zaher FM, Gonik B, Evans MI, Diamond MP, et al. Expression and regulation of vascular endothelial growth factor in a first trimester trophoblast cell line. Placenta 2000; 21: 320-324.
10. Leisser C, Saleh L, Haider S, Husslein H, Sonderegger S, Knofler M. Tumour necrosis factor-alpha impairs chorionic gonadotrophin beta-subunit expression and cell fusion of human villous cytotrophoblast. Mol Hum Reprod 2006; 12: 601-609.
11. Phillips TA, Ni J, Hunt JS. Death-inducing tumor necrosis factor (TNF) superfamily ligands and receptors are transcribed in human placentas, cytotrophoblasts, placental macrophages, and placental cell lines. Placenta 2001; 22: 663-672.
12. Phillips TA, Ni J, Hunt JS. Cell-specific expression of B lymphocyte (APRIL, BLyS)- and Th2 (CD30LCD153)-promoting tumor necrosis factor superfamily ligands in human placentas. J Leukoc Biol 2003; 74: 81-87.
13. Salamonsen LA, Dimitriadis E, Jones RL, Nie G. Complex regulation of decidualization: a role for cytokines and proteases-a review. Placenta 2003; 17: S76-S85.
14. Kammerer U. Antigen-presenting cells in the decidua. Chem Immunol Allergy 2005; 89: 96-104.
15. Moore PA, Belvedere O, Orr A, Pieri K, LaFleur DW, Feng P, et al. BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. Science 1999; 285: 260-263.
16. Schneider P, MacKay F, Steiner V, Hofmann K, Bodmer JL, Holler N, et al. BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J Exp Med 1999; 189: 1747-1756.
17. Shu HB, Hu WH, Johnson H. TALL-1 is a novel member of the TNF family that is down-regulated by mitogens. J Leukoc Biol 1999; 65: 680-683.
18. Makhopadhyay A, Ni J, Zhai Y, Yu GL, Aggarwal BB. Identification and characterization of a novel cytokine, THANK, a TNF Homologue that activates apoptosis, nuclear factor-κB, and c-Jun NH2-terminal kinase. J Biol Chem 1999; 274: 15978-15981.
19. Gross JA, Johnston J, Mudri S, Enselman R, Dillon SR, Madden K, et al. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature 2000; 404: 995-999.
20. Mackay F, Schneider P, Rennert P, Browning J. BAFF and APRIL: a tutorial on B cell survival. Annu Rev Immunol 2003; 21: 231-264.
21. Paria BC, Reese J, Das SK, Dey SK. Deciphering the cross-talk of implantation: advances and challenges. Science 2002; 296: 2185-2188.
22. Lyall F. Mechanisms regulating cytotrophoblast invasion in normal pregnancy and pre-eclampsia. Aust N Z J Obstet Gynaecol 2006; 46: 266-273.
23. Coulam CB. Understanding the immunobiology of pregnancy and applying it to treatment of recurrent pregnancy loss. Early Pregnancy 2000; 4: 19-29.
24. Christiansen OB, Nielsen HS, Kolte AM. Future directions of failed implantation and recurrent miscarriage research. Reprod Biomed Online 2006; 13: 71-83.
25. Locksley RM, Killeen N, Lenardo MJ. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 2001; 104: 487-501.
26. Wegmann TG, Lin H, Guilbert L, Mosmann TR. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol Today 1993; 14: 353-356.
27. Xu LG, Wu M, Hu J, Zhai Z, Shu HB. Identification of downstream genes up-regulated by the tumor necrosis factor family member TALL-1. J Leukoc Biol 2002; 72: 410-416.
28. Moore KW, O'Garra A, de Waal Malefyt R, Vieira P, Mosmann TR. Interleukin-10. Annu Rev Immunol 1993; 11: 165-190.
29. Shurin MR, Lu L, Kalinski P, Stewart-Akers AM, Lotze MT. Th1/Th2 balance in cancer, transplantation and pregnancy. Springer Semin Immunopathol 1999; 21: 339-359.
30. Ostensen M, Forger F, Villiger PM. Cytokines and pregnancy in rheumatic disease. Ann NY Acad Sci 2006; 1069: 353-363.
31. Emmer PM, Nelen WL, Steegers EA, Hendriks JC, Veerhoek M, Joosten I. Peripheral Natural Killer cytotoxicity and CD56 (pos) CD16 (pos) cells increase during early pregnancy in women with a history of recurrent spontaneous abortion. Hum Reprod 2000;, 15: 1163-1169.
32. Kwak-Kim JY, Gilman-Sachs A, Kim CE. T helper 1 and 2 immune responses in relationship to pregnancy, nonpregnancy, recurrent spontaneous abortions and infertility of repeated implantation failures. Chem Immunol Allergy 2005; 88: 64-79.
33. Ahmed A, Perkins J. Angiogenesis and intrauterine growth restriction. Baillière's Best Pract Res Clin Obstet Gynaecol 2000; 14: 981-998.
34. Nardo LG, Vascular endothelial growth factor expression in the endometrium during the menstrual cycle implantation window and early pregnancy. Curr Opin Obstet Gynecol 2005, 17: 419-423.
35. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000; 6: 389-395.
36. Folkman J, D'Amore PA. Bloods vessel formation: what is its molecular basis? Cell 1996; 87: 1153-1155.
37. Risau W. Mechanisms of angiogenesis. Nature 1997; 386: 671-674.
38. Carmeliet P. Angiogenesis in health and disease. Nat Med 2003; 9: 653-660.
39. Folkman J. Fundamental concepts of the angiogenic process. Curr Mol Med 2003; 3: 643-651.
40. Thompson JS, Bixler SA, Qian T, Vora K, Scott ML, Cachero TG, et al. BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF. Science 2001; 293: 2108-2111.